• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Product › Details

cancer immunotherapy (immuno-oncology, I-O)

	Next higher product group	cancer drug
	Status	2012-10-06

Record changed: 2021-01-07

Advertisement

More documents for cancer immunotherapy (immuno-oncology, I-O)

• [1] T-Knife GmbH. (1/19/21). "Press Release: T-Knife Announces Appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. Landis as Chief Business Officer & Chief Financial Officer". San Francisco, CA & Berlin....
• [2] Boehringer Ingelheim. (1/12/21). "Press Release: Boehringer Ingelheim and Enara Bio Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies". Ingelheim, Oxford & London....
• [3] Immunocore Ltd.. (1/11/21). "Press Release: Immunocore Announces Closing of $75.0 Million Series C Round". Oxfordshire, Conshohocken, PA & Rockville, MD....
• [4] Affimed N.V.. (1/11/21). "Press Release: Affimed Announces €25 Million Debt Financing Agreement with Silicon Valley Bank". Heidelberg....
• [5] Atomwise, Inc.. (12/18/20). "Press Release: Atomwise and FutuRx Launch A2i Therapeutics – a New Immuno-Oncology Company Funded by Leading Biopharma VCs and the Israeli Innovation Authority". San Francisco, CA & Ness Ziona....
• [6] Nouscom AG. (12/11/20). "Press Release: Nouscom Appoints Göran Ando MD as Chairman and Richard Davis PhD as Chief Business Officer". Basel....
• [7] Boehringer Ingelheim. (12/9/20). "Press Release: Boehringer Ingelheim to Acquire Labor Dr. Merk & Kollegen to Strengthen its Next Generation Cancer Immunology Program". Ingelheim & Ochsenhausen....
• [8] Novo Holdings A/S. (11/23/20). "Press Release: ISD Immunotech, a Novo Seeds Portfolio Company, Enters Strategic Research Collaboration for the Development of a Novel Lupus Treatment". Copenhagen....
• [9] Twist Bioscience Corporation. (10/13/20). "Press Release: Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies". South San Francisco, CA, Amsterdam & New York, NY....
• [10] Sensei Biotherapeutics, Inc.. (10/7/20). "Press Release: Sensei Biotherapeutics Announces $28.5 Million Financing To Advance Clinical Pipeline and Immunophage Platform Targeting Multiple Cancers". Boston, MA & Gaithersburg, MD....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.